Triterpenic Acid Amides as Potential Inhibitors of the SARS-CoV-2 Main Protease Full article
| Journal |
Molecules
, E-ISSN: 1420-3049 |
||||||
|---|---|---|---|---|---|---|---|
| Output data | Year: 2023, Volume: 28, Number: 1, Pages: 303 Pages count : 1 DOI: 10.3390/molecules28010303 | ||||||
| Tags | triterpene amide; SARS-CoV-2; main protease; molecular modeling; FRET; antiviral | ||||||
| Authors |
|
||||||
| Affiliations |
|
Abstract:
Although the incidence and mortality of SARS-CoV-2 infection has been declining during
the pandemic, the problem related to designing novel antiviral drugs that could effectively resist
viruses in the future remains relevant. As part of our continued search for chemical compounds that
are capable of exerting an antiviral effect against the SARS-CoV-2 virus, we studied the ability of
triterpenic acid amides to inhibit the SARS-CoV-2 main protease. Molecular modeling suggested that
the compounds are able to bind to the active site of the main protease via non-covalent interactions.
The FRET-based enzyme assay was used to reveal that compounds 1e and 1b can inhibit the SARSCoV-2 main protease at micromolar concentrations.
Cite:
Baev D.S.
, Blokhin M.E.
, Chirkova V.Y.
, Belenkaya S.V.
, Luzina O.A.
, Yarovaya O.I.
, Salakhutdinov N.F.
, Shcherbakov D.N.
Triterpenic Acid Amides as Potential Inhibitors of the SARS-CoV-2 Main Protease
Molecules. 2023. V.28. N1. P.303. DOI: 10.3390/molecules28010303 WOS Scopus РИНЦ OpenAlex
Triterpenic Acid Amides as Potential Inhibitors of the SARS-CoV-2 Main Protease
Molecules. 2023. V.28. N1. P.303. DOI: 10.3390/molecules28010303 WOS Scopus РИНЦ OpenAlex
Dates:
| Submitted: | Dec 9, 2022 |
| Accepted: | Dec 28, 2022 |
| Published print: | Dec 30, 2022 |
Identifiers:
| Web of science: | WOS:000909074900001 |
| Scopus: | 2-s2.0-85145736389 |
| Elibrary: | 59284445 |
| OpenAlex: | W4313472282 |